Omeprazole Accord Healthcare

Omeprazole, the active ingredient in Omeprazole Accord Healthcare, is a proton pump inhibitor (PPI) presented as a tablet for oral use. It reduces stomach acid production and is used to treat conditions such as gastro‑oesophageal reflux disease and peptic ulcer disease in adults and children.

GNH USA supplies Omeprazole Accord Healthcare as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Omeprazole is a proton pump inhibitor that acts on gastric acid secretion pathways. - Gastro‑oesophageal reflux disease (GERD): provides relief of heartburn and promotes healing of erosive esophagitis. - Peptic ulcer disease: accelerates ulcer healing and reduces recurrence risk. - Zollinger‑Ellison syndrome: controls excessive gastric acid production associated with gastrin‑secreting tumours. - NSAID‑associated ulcer prophylaxis: lowers the risk of ulcer development in patients requiring long‑term NSAID therapy.

Adverse reactions to omeprazole vary in frequency and severity.

Common Side Effects: - Headache: mild to moderate intensity. - Diarrhoea: usually self‑limiting. - Nausea: occasional and transient. - Abdominal pain: mild discomfort. - Flatulence: occasional gas buildup. - Constipation: infrequent but reported.

Serious or Rare Side Effects: - Clostridioides difficile infection: severe colitis risk. - Acute interstitial nephritis: kidney inflammation. - Severe hypersensitivity reactions: including Stevens‑Johnson syndrome. - Osteoporotic fractures: increased risk with long‑term use. - Hypomagnesemia: low magnesium levels with prolonged therapy. - Liver enzyme elevation: rare hepatic impact.

When prescribing omeprazole, clinicians should consider several safety aspects. - Assess renal and hepatic function: dose adjustment may be required in impairment. - Review concomitant medications: potential for drug‑drug interactions. - Monitor long‑term users: watch for bone density loss and magnesium levels. - Use caution in pregnancy: weigh benefits against potential risks. - Avoid in patients with known hypersensitivity to PPIs. - Store at ambient temperature: keep in original packaging, protect from moisture and light.

Omeprazole can interact with several medicines, requiring attention to avoid reduced efficacy or increased toxicity.

Major Interactions (Avoid): - Clopidogrel: reduced antiplatelet effect. - Atazanavir: decreased antiviral absorption. - Dasatinib: lowered cancer‑drug exposure.

Moderate Interactions (Monitor Closely): - Warfarin: potential INR elevation. - Phenytoin: altered serum levels. - Methotrexate: increased risk of toxicity. - Digoxin: possible increased concentrations. - Ketoconazole: reduced antifungal absorption.